Download PDF
CC BY-NC-ND 4.0 · South Asian J Cancer 2020; 9(02): 115-119
DOI: 10.1055/s-0040-1721176
Original Article: Supportive Care and Others

Bacteriological Profile and Antibiotic Sensitivity Pattern of Clinical Isolates in a Tertiary Cancer Care Center in the Northeast India

Abhijit Talukdar
1   Department of Surgical Oncology, Dr. B. Borooah Cancer Institute, Guwahati, Assam, India
,
Rashmisnata Barman
2   Department of Microbiology, Dr. B. Borooah Cancer Institute, Guwahati, Assam, India
,
Anupam Sarma
3   Department of Pathology, Dr. B. Borooah Cancer Institute, Guwahati, Assam, India
,
Jagannath Dev Sharma
3   Department of Pathology, Dr. B. Borooah Cancer Institute, Guwahati, Assam, India
,
Manigreeva Krishnatreya
4   Department of Cancer Epidemiology and Biostatistics, Dr. B. Borooah Cancer Institute, Guwahati, Assam, India
,
Munlima Hazarika
5   Department of Medical Oncology, Dr. B. Borooah Cancer Institute, Guwahati, Assam, India
,
Amal Chandra Kataki
6   Department of Gynecologic Oncology, Dr. B. Borooah Cancer Institute, Guwahati, Assam, India
› Author Affiliations Funding Nil.
› Further Information
   Permissions and Reprints

Abstract

Background This study was performed to determine the bacteriological profile and antibiotic sensitivity pattern of culture samples of patients with cancer at our institute. The study was undertaken to formulate an antibiotic policy for the treatment of infection in these patients.

Materials and Methods The study was performed in the Department of Microbiology of a regional cancer center during the period from January 2017 to December 2017. Samples were collected under all aseptic precaution, and they were processed as per the Clinical and Laboratory Standard Institute Guideline 2017.

Results A total of 464 clinical samples (urine, blood, sputum, pus, etc.) were collected and processed for culture, of which 198 (42.67%) samples showed culture positive that were identified as per standard recommended procedures and antibiotic susceptibility testing was performed on isolates as per the Clinical Laboratory Standard Institute guidelines 2017. Escherichia coli (48), Staphylococcus aureus, (45) Klebsiella pneumoniae (52), Coagulase-negative Staphylococcus (17), and Pseudomonas aeruginosa (15) were most commonly encountered. Of the 132 Gram-negative isolates, 101 (76.5%) were extended-spectrum β-lactamase producers. Among the 45 staphylococcal isolates, 18 (40%) were methicillin-resistant S. aureus.

Conclusion The present study reveals microbiological profile in patients attending our cancer institute.

Keywords

extended-spectrum β-lactamase - immunocompromised - methicillin-resistant Staphylococcus aureus - multidrug resistance


Publication History

Article published online:
14 December 2020

© 2020. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Singh R, Jain S, Chabbra R, Naithani R, Upadhyay A, Walia M. Characterization and anti-microbial susceptibility of bacterial isolates: experience from a tertiary care cancer center in Delhi. Indian J Cancer 2014; 51 (04) 477-480
    CrossrefPubMedGoogle Scholar
  • 2 Bhat V, Gupta S, Kelkar R. et al. Bacteriological profile and antibiotic susceptibility patterns of clinical isolates in a tertiary care cancer center. Indian J Med Paediatr Oncol 2016; 37 (01) 20-24
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Hughes WT, Armstrong D, Bodey GP. et al. Infectious Diseases Society of America. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34 (06) 730-751
    CrossrefPubMedGoogle Scholar
  • 4 Nazneen S, Mukta K, Santosh C, Borde A. Bacteriological trends and antibiotic susceptibility patterns of clinical isolates at Government Cancer Hospital, Marathwada. Indian J Cancer 2016; 53 (04) 583-586
    CrossrefPubMedGoogle Scholar
  • 5 Rolston KV. Infections in cancer patients with solid tumors: a review. Infect Dis Ther 2017; 6 (01) 69-83
    CrossrefPubMedGoogle Scholar
  • 6 Koneman EW, Allen SD, Janda WM, Schreckember PC, Winn WC. Koneman’s Colour Atlas and Textbook of Diagnostic Microbiology. 6th edition. New York: Lippincott; 2006: 97-99
    Google Scholar
  • 7 Forbes BA, Sahm DF, Weissfeld AS. Bailey and Scott’s Diagnostic Microbiology. 12th edition. Missouri: Mosby Elsevier; 2007: 779
    Google Scholar
  • 8 Clinical and Laboratory Standards Institute. Clinical and Laboratory Standards Institute 2016. Performance Standards for Antimicrobial Susceptibility Testing. Twenty-Second Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2016
    Google Scholar
  • 9 Zembower TR. Epidemiology of infections in cancer patients. Cancer Treat Res 2014; 161: 43-89
    CrossrefPubMedGoogle Scholar
  • 10 Henao-Martínez AF, González-Fontal GR, Castillo-Mancilla JR, Yang IV. Enterobacteriaceae bacteremias among cancer patients: an observational cohort study. Int J Infect Dis 2013; 17 (06) e374-e378
    CrossrefPubMedGoogle Scholar
  • 11 Menezes GA, Harish BN, Sujatha S, Vinothini K, Parija SC. Emergence of vancomycin-intermediate Staphylococcus species in southern India. J Med Microbiol 2008; 57 (Pt 7) 911-912
    CrossrefPubMedGoogle Scholar
  • 12 Eshwara VK, Munim F, Tellapragada C. et al. Staphylococcus aureus bacteremia in an Indian tertiary care hospital: observational study on clinical epidemiology, resistance characteristics, and carriage of the Panton-Valentine leukocidin gene. Int J Infect Dis 2013; 17 (11) e1051-e1055
    CrossrefPubMedGoogle Scholar
  • 13 Ghosh I, Raina V, Kumar L. et al. Profile of infections and outcome in high-risk febrile neutropenia: experience from a tertiary care cancer center in India. Med Oncol 2012; 29 (02) 1354-1360
    CrossrefPubMedGoogle Scholar
  • 14 Hurtado IC, Sánchez DP, Espinal DA, Garcés C. [Clinical and laboratory evolution of the febrile neutropenia episodes in pediatric patients hospitalized in a Colombian hospital in 2007-2009]. Rev Chilena Infectol 2012; 29 (06) 672-676
    CrossrefPubMedGoogle Scholar